Corrigendum to “Sodium-Glucose Cotransporter 2 Inhibitors Reduce the Risk of Hospitalization for Heart Failure and Amputation Rate Compared With Incretin-Based Therapy in Patients With Diabetic Foot Disease: A Nationwide Population-Based Study” [Endocrine Practice 30 (2024) 424-430, (S1530891X24000624), (10.1016/j.eprac.2024.01.016)]

The authors regret that the affiliation for authors were incorrect and should be as follows Yi-Hsuan Lin MD^1,2, Chia-Hung Lin MD, PhD^1,2,3, Yu-Chih Lin MD⁴, Yu-Yao Huang MD, PhD⁵, An-Shun Tai PhD⁶, Shih-Chen Fu PhD⁷, Sheng-Hsuan Lin MD, ScD, ScM^8,9 1 Division of Endocrinology and Metabolism, Department of Internal Medicine, Chang Gung Memorial Hospital, Linkou, Taiwan2 Department of Biological Science and Technology, National Yang Ming Chiao Tung University, Hsinchu, Taiwan3 Department of Chinese Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan4 Department of Medical Nutrition Therapy, Chang Gung Memorial Hospital, Linkou, Taiwan5 Department of Orthopedic Surgery, Chang Gung Memorial Hospital, Linkou, Taiwan6 Department of Statistics, National Cheng Kung University, Tainan, Taiwan7 Department of Biochemistry and Molecular Medicine, National Dong Hwa University, Hualien, Taiwan8 Institute of Statistics, National Yang Ming Chiao Tung University, Hsinchu, Taiwan9 Institute of Data Science and Engineering, National Yang Ming Chiao Tung University, Hsinchu, TaiwanThe authors would like to apologise for any inconvenience caused.